How does Q-Trust help nutraceutical brands with KYB requirements?

Q-Trust automates the KYB (Know Your Business) process by verifying licenses and credentials against official registries and aggregating compliance documentation into a blockchain-anchored single source of truth. This transparency builds trust with financial institutions and demonstrates to regulators that the brand is operating as a legitimate, compliant business under federal guidelines — reducing the perceived risk that leads banks and processors to restrict or terminate accounts in the nutraceutical and supplement space.

Why is the GRAS standard becoming more critical for nutraceutical and supplement products?

The FDA is tightening the Generally Recognized as Safe (GRAS) standard so that ingredient safety determinations must now be submitted to the FDA for official review, rather than self-affirmed by company-appointed expert panels. As Qredible CEO Brian Fitzpatrick explained, brands can no longer rely on assembling their own expert panel to affirm ingredient safety — the FDA will now review and decide whether an ingredient qualifies. This significantly raises the compliance barrier for new nutraceutical ingredients and makes it essential that brands maintain comprehensive documentation of their ingredient safety evidence.

How are banks and payment processors enforcing compliance for nutraceutical and CBD businesses?

Financial institutions are increasingly acting as a first line of regulatory enforcement for nutraceutical and CBD merchants — terminating accounts of businesses making unverified health claims or selling non-compliant products, even before the FDA or FTC takes formal action. As Noah Fitzgerald explains, banks and payment processors must know who they're doing business with — if a merchant is selling products illegally or making unverified health claims, that financial institution is responsible. This financial enforcement by proxy means nutraceutical brands must meet the compliance standards of their payment processors and banks — not just their regulatory agencies — to maintain stable business operations.

What are the risks for everyday businesses selling hemp or CBD products without compliance infrastructure?

As the hemp and CBD market has mainstreamed, businesses that weren't previously considered high-risk — restaurants, delis, liquor stores — are increasingly stocking THC beverages and CBD products without understanding that doing so reclassifies them as high-risk merchants in the eyes of their payment processors. As Noah Fitzgerald describes, these businesses are putting THC beverages in coolers next to soft drinks without realizing they are now a high-risk business. Without compliance infrastructure and proper documentation, these merchants risk sudden account termination when processors conduct risk reviews — cutting off their ability to accept card payments overnight.

How quickly can Qredible identify compliance issues for nutraceutical and wellness brands?

Q-Audit can determine whether a company's digital presence is compliant in approximately six minutes — scanning websites, product pages, and marketing claims for FDA disclaimer gaps, FTC advertising substantiation issues, and regulatory red flags. During a live Qredible broadcast, Brian Fitzpatrick ran a real-time compliance scan on a merchant who was doing almost everything right but was missing one FDA disclaimer — and they fixed it immediately. That kind of proactive detection prevents the warning letters, payment processor alerts, and account terminations that follow when compliance issues are discovered by regulators or processors instead.

How does compliance become a competitive advantage for nutraceutical and CBD brands?

As FDA enforcement intensifies and financial institutions tighten underwriting for high-risk merchants, brands with robust automated compliance infrastructure gain significant competitive advantages: stable payment processing relationships that competitors lose; faster onboarding approvals from banks and processors that recognize Q-Certified brands as lower risk; preferential marketplace access from platforms requiring verified compliance credentials; and the ability to adapt quickly to regulatory changes rather than scrambling reactively. Technology is changing how compliance is managed — helping companies shift from reaction to prevention, from fear to confidence. For nutraceutical and CBD brands, that shift is increasingly the difference between sustainable growth and sudden business disruption.

From Wild West to Watchdog: The Rising Regulatory Pressure on Nutraceuticals, Peptides & CBD

Category: Business Learning Center Videos

Author: The Qredible Team

Date: October 8, 2025

For years, the nutraceutical and CBD industries have operated in a gray zone—booming with innovation but light on oversight. That era is ending.

During a recent Qredible Live Broadcast, CEO Brian Fitzpatrick and CRO Noah Fitzgerald discussed how rising regulatory pressure on nutraceuticals and adjacent markets like peptides and CBD is reshaping the health and wellness space. Their conversation revealed how government agencies, banks, and even payment processors are working in tandem to tighten control over an increasingly crowded market of supplements, hemp-based products, and alternative therapies.

As Fitzpatrick put it, “We’re seeing this convergence between eastern and western medicine—people want to take control of their wellness—but the rise in unregulated products means the oversight has to catch up.”

A Perfect Storm of Growth and Oversight

The growth of nutraceuticals, peptides, and CBD products has been explosive. Consumers are increasingly turning to natural or functional alternatives to pharmaceuticals. Yet with that growth comes a flood of new products, many with questionable ingredients or exaggerated claims.

Fitzpatrick noted that the federal and state governments are now intensifying enforcement to address these risks. “We’ve got RFK Jr. leading Health and Human Services, and while he’s a fan of supplements, he’s also a fan of safety,” he said. “We’re going to see more FDA enforcement—even though the FDA has been under pressure and underfunded.”

This shift is driven by real-world consequences. “We’re seeing more adverse health incidents because of inconsistent product quality and misleading claims,” Fitzpatrick explained. “The rapid proliferation of unregulated products has forced regulators to take a harder stance.”

That harder stance includes tightening the GRAS (Generally Recognized As Safe) standard. “It used to be that you could bring your own panel of experts to approve your ingredients,” Fitzpatrick said. “Now you’re going to have to submit your GRAS standards to the FDA for review—and they’ll decide whether to give you the thumbs up or down.”

When Oversight Extends Beyond the FDA

The regulatory web doesn’t stop with government agencies. Financial institutions are now enforcing compliance by proxy. “Even though the FDA and FTC set the rules,” Fitzpatrick explained, “the enforcement has been coming in from the financial side of the business.”

Fitzgerald elaborated: “Banks and payment processors have to know who they’re doing business with. If a merchant is selling products illegally or making unverified health claims, that bank is responsible. They’re the first line of defense.”

This growing overlap between financial risk and regulatory compliance has forced companies in the supplement and CBD sectors to think differently about how they market, label, and distribute products. “The technology makes it easier to find these issues now,” Fitzgerald said. “It’s getting really hard to hide.”

The End of the ‘Wild West’

Fitzgerald pointed to a vivid example: “I saw a product the other day that was a 10,000-milligram bag of THC gummies. That’s not just reckless—it’s dangerous. And when states see things like that, they freak out. They have to shut it down.”

That kind of behavior has created ripple effects throughout the industry. States are stepping in to curb high-dose or misleadingly labeled products, while financial partners are pulling back from merchants that don’t meet compliance standards.

“We’re seeing what used to be low-risk businesses—restaurants, delis, liquor stores—suddenly get flagged,” Fitzgerald explained. “They’re putting THC beverages in coolers next to the soft drinks, not realizing they’re now a high-risk business in the eyes of their payment processors.”

It’s an unintended consequence of the market’s success: as cannabis and hemp derivatives become more mainstream, more businesses unknowingly step into regulatory territory they’re not prepared for.

Fitzpatrick summed it up: “Compliance used to be a black box. Businesses didn’t know what banks or regulators were reviewing. That doesn’t work anymore. We need a transparent system where everyone can see and understand what’s expected.”

How Technology Is Closing the Gap

Qredible’s mission centers on that transparency—using automation and technology to make compliance accessible to every player in the supply chain.

“We can scan a company’s website and know within minutes whether it’s compliant,” Fitzgerald said. “What used to take a full-time compliance role now takes a couple of hours a month.”

Fitzpatrick shared a real-world example from the broadcast: “We ran a live scan with a merchant who was doing almost everything right—but they were missing one FDA disclaimer. They fixed it immediately. That’s the kind of visibility companies need before they get a warning letter or lose their payment processor.”

This proactive approach doesn’t just protect businesses—it strengthens the entire ecosystem. “It’s about sustainability,” Fitzgerald said. “We want to help the good actors stay in business and raise the bar for the entire industry.”

Compliance as a Competitive Advantage

The conversation made it clear: compliance isn’t just a legal obligation—it’s becoming a competitive differentiator.

“Technology is changing how we think about compliance,” Fitzpatrick said. “We’re helping companies shift from reaction to prevention, from fear to confidence.”

For the supplement and CBD markets, that means understanding not just what’s legal, but what’s sustainable. With heightened oversight from the FDA, financial institutions, and state governments, the businesses that succeed will be those that treat compliance as a core business function—not an afterthought.

Fitzgerald emphasized that mindset: “It’s not about catching bad actors—it’s about giving the good ones the tools to stay ahead. That’s how we help these industries thrive.”

The Next Chapter for Health and Wellness Regulation

As the wellness market continues to grow, the Rising Regulatory Pressure on Nutraceuticals is a sign of maturity, not decline. Oversight is increasing because the industry matters more than ever—to consumers, to public health, and to financial systems that power it.

For brands that embrace transparency and technology, the future isn’t something to fear. It’s a chance to build credibility, protect consumers, and grow with integrity.

Or, as Fitzpatrick summed it up perfectly: “We’re not here to make life harder for businesses. We’re here to make compliance easier—and to help the industries we love survive and thrive.”